Argonne maintains a wide-ranging science and technology portfolio that seeks to address complex challenges in interdisciplinary and innovative ways. Below is a list of all articles, highlights, profiles, projects, and organizations related specifically to genetics.
Argonne’s collaboration with the Discovery Partners Institute helps public health officials track COVID variants and infectious diseases across Illinois. The system was honored among the most innovative new products or services brought to market in 2022.
New research shows cells gather more data than once believed inside the thalamus, a relay station of sensory and motor abilities in the brain. That could change how medicine treats schizophrenia, epilepsy and other brain disorders.
The Center for Nanoscale Materials develops and applies machine learning and data science approaches for large-scale atomistic simulations and characterization of nanoscale systems. Also available is high performance computing.
Christopher Henry’s primary research is in the field of computational biology with a focus on the prediction of phenotype from genome through the use of comparative genomics, metabolic modeling, and dynamic cellular community models.
CSGID applies state-of-the-art high-throughput structural biology technologies to experimentally characterize the three-dimensional atomic structure of targeted proteins from certain pathogens causing emerging and re-emerging infectious diseases.